Vikas Gupta

We are very bullish on the growth opportunities in domestic as well as in the international businesses and are on track to deliver our full-year guidance.

We will continue to outperform the market at least by 100-150 basis points.

From the EBITDA guidance perspective, I see somewhere between 19.5%-20% should be our EBITDA for the full year.

We are very hopeful that very shortly we will get the approval for GLP-1. We should be on track and amongst the first players to be out there in India when the patent expires.

We'll continue to outperform the market at least by 100 to 150 basis points.

I see somewhere between 19 and a half to 20 should be our EBITDA for the full year.

We are hopeful that we should be closing the year close to a double digit kind of growth from US.

We are strategically accelerating our focus on the non-U.S. business segment by strengthening our presence in high potential non-U.S. markets as well and capturing new opportunities that align with our long-term growth ambitions.

I think if the year progresses the way we are seeing for some more time then definitely we would overachieve on the guidance that we have given.

Our focus on India business is stronger than ever. If it takes to put more investments in India business behind opportunities that we can grow continuously, we have been looking at that, evaluating that, doing that.

We ended the year on a good note with healthy growth in our India business during Q4 and improved profitability and margins for the full year.

Our focus remains on positioning the company for sustained growth and creating long-term value for our shareholders.